Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Absci Corp - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
ABSI
Nasdaq
8731
https://www.absci.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Absci Corp
Absci to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- Mar 28th, 2024 8:05 pm
Absci Corp (ABSI) Earnings: Misses Revenue Estimates and Reports Increased Net Loss
- Mar 23rd, 2024 9:31 am
Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results
- Mar 21st, 2024 11:30 am
11 Stocks Insiders are Buying Now
- Mar 12th, 2024 9:34 pm
Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
- Mar 1st, 2024 9:01 pm
Absci Corporation (ABSI) Surges 10.0%: Is This an Indication of Further Gains?
- Mar 1st, 2024 11:49 am
Absci Announces Pricing of Public Offering of Common Stock
- Feb 28th, 2024 3:20 am
Absci Announces Proposed Public Offering of Common Stock
- Feb 27th, 2024 9:01 pm
Is Centene (CNC) Stock Outpacing Its Medical Peers This Year?
- Feb 21st, 2024 2:40 pm
Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AI
- Feb 21st, 2024 12:30 pm
Absci to Participate in Upcoming Investor Conferences
- Feb 20th, 2024 1:00 pm
Is Absci Corporation (ABSI) Outperforming Other Medical Stocks This Year?
- Feb 5th, 2024 2:40 pm
Both retail investors who control a good portion of Absci Corporation (NASDAQ:ABSI) along with institutions must be dismayed after last week's 15% decrease
- Jan 21st, 2024 1:18 pm
Absci Appoints Professor Sir Mene Pangalos to its Board of Directors
- Jan 10th, 2024 12:30 pm
Absci to Present Preclinical Data for ABS-101, A Potential Best-in-Class Anti-TL1A Antibody Development Program, at 42nd Annual J.P. Morgan Healthcare Conference
- Jan 8th, 2024 12:00 pm
Absci to Participate in the 26th Annual Needham Growth Conference
- Jan 3rd, 2024 1:00 pm
Absci to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
- Dec 28th, 2023 1:00 pm
Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug Pipeline
- Dec 20th, 2023 12:30 pm
Absci (ABSI) Up on AstraZeneca Deal to Design New Cancer Therapy
- Dec 5th, 2023 1:11 pm
Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate
- Dec 4th, 2023 12:30 pm
Scroll